Lincoln Pharmaceuticals Ltd
NSE:LINCOLN

Watchlist Manager
Lincoln Pharmaceuticals Ltd Logo
Lincoln Pharmaceuticals Ltd
NSE:LINCOLN
Watchlist
Price: 557.75 INR 0.84% Market Closed
Market Cap: 11.2B INR

During the last 3 months Lincoln Pharmaceuticals Ltd insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 30% over this period (open performance analysis).

The last transaction was made on Feb 27, 2024 by Patel Nishitkumar Maheshbhai (Whole Time Director) , who sold 733.5k INR worth of LINCOLN shares.

Last Transactions:
Patel Nishitkumar Maheshbhai
Whole Time Director
₹-733.5k
Renukaben Maheshbhai Patel
Independent Director
₹-1.1m
Patel Nishitkumar Maheshbhai
Whole Time Director
₹-751.1k
Anand Arvindbhai Patel
Whole Time Director
₹+12.8m
Ashish Rajanibhai Patel
Executive Director
₹+147.3m
Kalpanaben Rajnibhai Patel
Chairman
₹-147.3m
Munjal Mahendrabhai Patel
Chairman
₹+23.5m
Ashish Rajanibhai Patel
Executive Director
₹+9.5m
Munjal Mahendrabhai Patel
Chairman
₹+19.9m
Ashish Rajanibhai Patel
Executive Director
₹+15m
Munjal Mahendrabhai Patel
Chairman
₹+14.6m
Munjal Mahendrabhai Patel
Chairman
₹+14.6m
Ashish Rajanibhai Patel
Executive Director
₹+14.9m
Munjal Mahendrabhai Patel
Chairman
₹+14.8m
Ashish Rajanibhai Patel
Executive Director
₹+14.9m
Ashish Rajanibhai Patel
Executive Director
₹+14.9m
Munjal Mahendrabhai Patel
Chairman
₹+15m
Ashish Rajanibhai Patel
Executive Director
₹+14.8m
Munjal Mahendrabhai Patel
Chairman
₹+4.1m
Ashish Rajanibhai Patel
Executive Director
₹+9m
Munjal Mahendrabhai Patel
Chairman
₹+9.7m
Munjal Mahendrabhai Patel
Chairman
₹+10m
Ashish Rajanibhai Patel
Executive Director
₹+8.8m
Munjal Mahendrabhai Patel
Chairman
₹+3.1m
Ashish Rajanibhai Patel
Executive Director
₹+3.4m
Munjal Mahendrabhai Patel
Chairman
₹+9m
Ashish Rajanibhai Patel
Executive Director
₹+9.9m
Ashish Rajanibhai Patel
Executive Director
₹+3.3m
Munjal Mahendrabhai Patel
Chairman
₹+10m
Ashish Rajanibhai Patel
Executive Director
₹+11.7m
Munjal Mahendrabhai Patel
Chairman
₹+9.8m
Ashish Rajanibhai Patel
Executive Director
₹+3.5m
View All Transactions

During the last 3 months Lincoln Pharmaceuticals Ltd insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 30% over this period (open performance analysis).

The last transaction was made on Feb 27, 2024 by Patel Nishitkumar Maheshbhai (Whole Time Director) , who sold 733.5k INR worth of LINCOLN shares.

Sold
0-3
months
0 INR
0
3-6
months
0 INR
0
6-9
months
0 INR
0
9-12
months
0 INR
0
Bought
0-3
months
No Insider Transactions
0
0 INR
3-6
months
No Insider Transactions
0
0 INR
6-9
months
No Insider Transactions
0
0 INR
9-12
months
No Insider Transactions
0
0 INR

Lincoln Pharmaceuticals Ltd
Insider Trading Chart

Lincoln Pharmaceuticals Ltd
Last Insider Transactions

Global
Insiders Monitor

Lincoln Pharmaceuticals Ltd
Glance View

Market Cap
11.2B INR
Industry
Pharmaceuticals

Lincoln Pharmaceuticals Ltd. is a holding company, which engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat. The firm offers products, such as tablets, capsules, liquid injection, cream in tubes, dry power injection, liquid in bott, liquid injection and pharma products. The company has operations in cardiac, diabetic, anti-malarial, anti-biotics, cephalosporins, analgesic, antipyretics, vitamin-minerals and iron preparations, among others. The firm serves approximately 60 countries in Europe, Latin America, Africa, Asia Pacific, Southeast Asia and 26 States across India. The firm's products include ARHL Tablet (used to treat chloroquine resistant falciparum malaria symptoms), Ibuprofen Tablet (used to treat pain, fever, and inflammation), Dolomol Tablet (used to treat aches and pains), Namcold Tablet (used to treat common cold symptoms) and Tinnex Capsule used to treat tinnitus.

LINCOLN Intrinsic Value
797.25 INR
Undervaluation 30%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top